These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2844638)

  • 41. The effects of pre-existing coxsackievirus B4 myocardial disease on the expression of coxsackievirus B3 myocarditis.
    Khatib R; Reyes MP; Khatib G; Giraldo A
    Can J Cardiol; 1993 Jun; 9(5):444-7. PubMed ID: 8394194
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Induction of antigen specific peripheral humoral tolerance to cardiac myosin does not prevent CB3-mediated autoimmune myocarditis.
    Horwitz MS; Ilic A; Fine C; Sarvetnick N
    J Autoimmun; 2005 Sep; 25(2):102-11. PubMed ID: 16011890
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Coxsackie B myocarditis.
    Bowles NE; Richardson PJ; Olsen EG; Archard LC
    Biomed Pharmacother; 1987; 41(4):197-8. PubMed ID: 3040137
    [No Abstract]   [Full Text] [Related]  

  • 44. Expression of vascular cell adhesion molecule-1 in murine hearts with acute myocarditis caused by coxsackievirus B3.
    Seko Y; Yagita H; Okumura K; Yazaki Y
    J Pathol; 1996 Dec; 180(4):450-4. PubMed ID: 9014868
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Coxsackie B4 virus murine myocarditis].
    Wang HY; Sun GX; Lin JZ; Liu TH; Wang SX; Zhou L; Li GR; Hu Y; Hu SS; Zeng X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Aug; 6(4):300-2. PubMed ID: 6098385
    [No Abstract]   [Full Text] [Related]  

  • 46. Coxsackievirus B3-induced chronic myocarditis in outbred NMRI mice.
    Merkle I; Tonew M; Glück B; Schmidtke M; Egerer R; Stelzner A
    J Hum Virol; 1999; 2(6):369-79. PubMed ID: 10774554
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Autoantibodies specific for the cardiac myosin isoform are found in mice susceptible to Coxsackievirus B3-induced myocarditis.
    Neu N; Beisel KW; Traystman MD; Rose NR; Craig SW
    J Immunol; 1987 Apr; 138(8):2488-92. PubMed ID: 3031159
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Therapeutic effect of yupingfeng san and shengmai yin on Coxsackie B viral myocarditis].
    Chen S; Chang P; Wang C
    Zhong Xi Yi Jie He Za Zhi; 1990 Jan; 10(1):20-1, 3. PubMed ID: 2161712
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Coxsackievirus myocarditis: prophylaxis and therapy with an interferon stimulator.
    Norris D; Loh PC
    Proc Soc Exp Biol Med; 1973 Jan; 142(1):133-6. PubMed ID: 4683231
    [No Abstract]   [Full Text] [Related]  

  • 50. Treatment of viral myocarditis caused by coxsackievirus B.
    Brunetti L; DeSantis ER
    Am J Health Syst Pharm; 2008 Jan; 65(2):132-7. PubMed ID: 18192257
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Autoimmune myocarditis: concepts and questions.
    Rose NR; Neumann DA; Herskowitz A
    Immunol Today; 1991 Aug; 12(8):253-5. PubMed ID: 1680335
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Monoclonal antibody to coxsackievirus B4 reacts with myocardium.
    Saegusa J; Prabhakar BS; Essani K; McClintock PR; Fukuda Y; Ferrans VJ; Notkins AL
    J Infect Dis; 1986 Feb; 153(2):372-3. PubMed ID: 3003209
    [No Abstract]   [Full Text] [Related]  

  • 53. Experimental drugs for treatment of autoimmune myocarditis.
    Han L; Guo S; Wang Y; Yang L; Liu S
    Chin Med J (Engl); 2014; 127(15):2850-9. PubMed ID: 25146626
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Myocarditis therapy].
    Gurevich MA; Iankovskaia MO
    Kardiologiia; 1981 Apr; 21(4):118-22. PubMed ID: 7253388
    [No Abstract]   [Full Text] [Related]  

  • 55. Towards precision disease-modelling in experimental myocarditis.
    Protonotarios A; Marelli-Berg F
    Cardiovasc Res; 2020 Aug; 116(10):1656-1657. PubMed ID: 32167527
    [No Abstract]   [Full Text] [Related]  

  • 56. Efficacy and Safety of Methotrexate for the Treatment of Autoimmune Virus-Negative Myocarditis: A Case Series.
    Campochiaro C; De Luca G; Sartorelli S; Tomelleri A; Esposito A; Candela C; Cavalli G; Dagna L
    J Clin Rheumatol; 2021 Jun; 27(4):e143-e146. PubMed ID: 30234673
    [No Abstract]   [Full Text] [Related]  

  • 57. Letter regarding the article "Immunomodulatory treatment for lymphocytic myocarditis-a systematic review and meta-analysis".
    Sarapultsev A; Kashtalap V; Sarapultsev P
    Heart Fail Rev; 2021 Jan; 26(1):215-216. PubMed ID: 32588155
    [No Abstract]   [Full Text] [Related]  

  • 58. [Cross-reacting antibodies destroy heart muscle tissue. Autoimmunologic mechanisms of infective myocarditis-- immunosuppressive drugs].
    Hartung HD
    Fortschr Med; 1988 Aug; 106(25):16. PubMed ID: 2844638
    [No Abstract]   [Full Text] [Related]  

  • 59. [Various aspects of the pathogenesis, clinical course and treatment of myocarditis. II].
    Bilińska ZT
    Kardiol Pol; 1987; 30(7):452-8. PubMed ID: 2824915
    [No Abstract]   [Full Text] [Related]  

  • 60. Trials of treating myocarditis in mice infected with coxsackie B3 viruses.
    Jaśkiewicz K
    Arch Immunol Ther Exp (Warsz); 1979; 27(1-2):99-103. PubMed ID: 220934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.